Educational Website About Tuberculosis Is Up
BOCA RATON, Fla. - Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that it has sponsored the website, stopTBnow.com, to educate the public about Tuberculosis.
“Many people believe that Tuberculosis was a disease of the past,” commented Rik J. Deitsch, Chairman and CEO of Nutra Pharma Corporation. “In fact, Tuberculosis, especially the drug-resistant XDR-TB strain, is a major concern for many developing countries that experience high rates of HIV infections,” he added.
The website features information about Tuberculosis: its symptoms, diagnosis and treatments, as well as a list of organizations dedicated to eradicating the disease.
“New Tuberculosis infections are occurring at a rate of one per second and the disease accounts for over a million deaths each year,” explained Neil Roth, President of Designer Diagnostics. “We believe that one of the primary strategies for preventing the spread of the disease and saving patient lives is to educate the public about early detection and recognizing its symptoms,” he added.
In January, Designer Diagnostics announced the positive results of an in-vitro analysis of its Tuberculosis test kit. Normal culturing methods can take as long as 10 weeks to produce results, whereas Designer Diagnostics test kits showed similar results within 10 days.
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.